This is a randomized prospective study. This objective is the impact of "relaxing touch" on the use of chemical restraint for patients in intensive care from the lifting of sedation until extubation.
Male or female over 18 years of age
Intubated and sedated man or woman
Extubation within 48 hours
Intubation of more than 48 hours in total
Known pregnancy
Patient who refused to participate in the study after the fact
Patients under long-term antidepressant treatment (treatment longer than 3 months)
Patients under guardianship or curatorship
Parallel
this arm will received relaxing touch (hands, feet, head) during 30 minutes twice a day
Other interventionPatients who will be included in this arm will receive massage twice a day of the head (10 minutes), feet (10 minutes) and hands (10 minutes)
chemical restraint
Comparison of the proportion of patients who received chemical restraint during the sedation release phase until extubation between the two groups (experimental and control arms)
self-extubations
Comparison of the proportion of self-extubations between the 2 groups
patient discomfort
Comparison of patient discomfort parameters between the 2 groups. The discomfort will be evaluated thank to body expression (unrest) and facial expression according to the BPS scale. The BPS scale is a behavioral pain scale used in intensive care for the sedated and ventilated adult patient. There discomfort parameters will be evaluated immediately after the relaxation touch, 30 min after, 60 min after and 90 min after. The patients included in a experimal group will be relaxation touch twice per day 12 hours apart
respiratory rate
Comparison of vital parameters between the 2 groups. Comparison between respiratory rate (/min), cardiac rate (/min), pressur (mmHG), and ventilation mode. Touch could relax patients and thus lower the values of vital parameters. The patients included in a experimal group will be relaxation touch twice per day 12 hours apart
Ratio chemical restraint use
Ratio per patient corresponding to the number of days with chemical restraint use between inclusion and exclusion/total number of days between inclusion and extubation.
Click on the lead sponsor to view all of their trials.
